See All Slides - tctmd.com

Slides

Presentation TCT 2012

ELM Presentation(4)

Presenter: Allen Jeremias

October 23, 2012

Presentation TCT 2012

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

Presenter: Fayaz Shawl

October 23, 2012

Presentation TCT 2012

TCT-33. Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The...

Presenter: Vasim Farooq

October 23, 2012

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

ELM Presentation(9)

Presenter: Jennifer Tremmel

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

History of SCAI and CCI

Presenter: Frank Hildner

October 23, 2012

Presentation TCT 2012

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Presenter: Mehdi Shishehbor

October 23, 2012

Advertisement

Slides

ELM Presentation(4)

Case 4: During Carotid Artery Stenting: Extracerebral or Access Vessel Related

TCT-33. Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The...

DESyneBD (Elixir Medical) Program Update

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

ELM Presentation(9)

Yes: The Quantitative Threshold Should Be Lowered!

History of SCAI and CCI

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content